internal quality assurance program for erbb2 (her2) testing improves the selection of breast cancer patients for treatment with trastuzumab内部质量保证计划erbb2(her2)测试改善乳腺癌患者的选择与曲妥珠单抗治疗.pdfVIP

Hindawi Publishing Corporation Pathology Research International Volume 2012, Article ID 261857, 5 pages doi:10.1155/2012/261857 Clinical Study Internal Quality Assurance Program for ERBB2 (HER2) Testing Improves the Selection of Breast Cancer Patients for Treatment with Trastuzumab Vittoria Martin, Antonella Camponovo, Morena Ghisletta, Massimo Bongiovanni, and Luca Mazzucchelli Institute of Pathology, via in Selva 24, 6600 Locarno, Switzerland Correspondence should be addressed to Vittoria Martin, vittoria.martin@ti.ch Receiv